Deciphering the genetic basis of Alzheimer's disease

Annual Review of Genomics and Human Genetics

Volumn 3, Issue , 2002, Pages 67-99

  Selkoe, Dennis J ^a   Podlisny, Marcia B ^a  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

amyloid precursor protein; Amyloid beta protein; Apolipoprotein E; Presenilin

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GAMMA SECRETASE; GENE PRODUCT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NOTCH RECEPTOR; PRESENILIN 1; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BRAIN REGION; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 6; CHROMOSOME 9; CLINICAL FEATURE; COGNITION; DISEASE COURSE; GENE INTERACTION; GENE LOCATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFE EXPECTANCY; MEMORY DISORDER; MISSENSE MUTATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW; RISK ASSESSMENT; SENILE PLAQUE; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CHROMOSOME MAPPING; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PRESENILIN-1; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 0036403702     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.3.022502.103022     Document Type: Review

References (155)

1. Annaert W, Esselens C, Baert V, Boeve C, Snellings G, et al. 2001. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32:579-89
2. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, et al. 1999. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J. Cell Bio. 147:277-94
3. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284:770-76
4. Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, et al. 1999. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96:15233-38
5. Berezovska O, Jack C, Deng A, Gastineau N, Rebeck GW, Hyman BT. 2001. Notch1 and amyloid precursor protein are competitive substrates for presenilin 1-dependent gamma-secretase cleavage. J. Biol. Chem. 276:30018-23
6. Berezovska O, Jack AC, McLean P, Aster JC, Hicks C, et al. 2000. Aspartate mutations in presenilin and γ-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservtion of Notch signaling. J. Neurochem. 75:583-93
7. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P. 1994. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci. Lett. 178:221-24
8. Bertram L, Tanzi RE. 2001. Dancing in the dark? The status of late-onset Alzheimer's disease genetics. J. Mol. Neurosci. 17:127-36
9. Biere AL, Ostaszewski B, Zhao H, Gillespie S, Younkin SG, Selkoe DJ. 1995. Coexpression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: Analysis of βAPP processing. Neurobiol. Dis. 2:177-87
10. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, et al. 1997. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939-45
11. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, et al. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-13
12. Breteler MM, Claus JJ, van Duijn CM, Launer LJ, Hofman A. 1992. Epidemiology of Alzheimer's disease. Epidemiol. Rev. 14:59-82
13. Brown MS, Ye J, Rawson RB, Goldstein JL. 2000. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 100:391-98
14. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, et al. 1999. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: Isoform-specific effects on neurodegeneration. J. Neurosci. 19:4867-80
15. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, et al. 1998. Evidence that tumor necrosis factor alpha-converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:27765-67
16. Cao X, Sudhof TC. 2001. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115-20
17. Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M, et al. 1998. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J. Biol. Chem. 273:3205-11
18. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, et al. 1992. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360:672-74
19. Citron M, Westaway D, Xia W, Carlson G, Diehl T, et al. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid βprotein in both transfected cells and transgenic mice. Nat. Med. 3:67-72
20. Collins JS, Perry RT, Watson B Jr, Harrell LE, Acton RT, et al. 2000. Association of a haplotype for tumor necrosis factor in siblings with lateonset Alzheimer disease: The NIMH Alzheimer Disease Genetics Initiative. Am. J. Med. Gen. 96:823-30
21. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, et al. 1994. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer's disease. Nat. Genet. 7:180-84
22. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261:921-23
23. Cotman CW. 1998. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging 19:S29-32
24. Cupers P, Bentahir M, Craessaerts K, Orlans I, Vanderstichele H, et al. 2001. The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein. J. Cell Bio. 154:731-40
25. Davis JA, Naruse S, Chen H, Eckman C, Younkin S, et al. 1998. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20:603-9
26. Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, et al. 2000. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66:196-204
27. De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, et al. 2001. Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10:1665-71
28. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518-22
29. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Gundula G, et al. 1998. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387-90
30. Duff K, Eckman C, Zehr C, Yu X, Prada C-M, et al. 1996. Increased amyloidβ42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-13
31. Eikelenboom P, Zhan SS, van Gool WA, Allsop D. 1994. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15:447-50
32. Eisenhauer PB, Johnson RJ, Wells JM, Davies TA, Fine RE. 2000. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: Increased toxicity of Dutch-type mutant. J. Neurosci. Res. 60:804-10
33. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, et al. 2000. Transition-state analogue inhibitors of γ-secretase bind directly to Presenilin-1. Nat. Cell Biol. 2:428-34
34. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, et al. 2002. Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate. Proc. Natl. Acad. Sci. USA 99:2720-25
35. Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT Jr. 1995. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formarion: Implications for the pathogenesis and treatement of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92:763-67
36. Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, et al. 1992. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. Biochemistry 31:10716-23
37. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, et al. 1999. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4:893-902
38. Glenner GG, Wong CW. 1984. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122:1131-35
39. Glenner GG, Wong CW. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-90
40. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-6
41. Goedert M, Spillantini MG. 2000. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta 1502:110-21
42. Gotz J, Chen F, van Dorpe J, Nitsch RM. 2001. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491-95
43. Goutte C, Hepler W, Mickey KM, Priess JR. 2000. Aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127:2481-92
44. Goutte C, Tsunozaki M, Hale VA, Priess JR. 2002. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. USA 99:775-79
45. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. 1995. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38:254-59
46. Griffin WS, Nicoll JA, Grimaldi LM, Sheng JG, Mrak RE. 2000. The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk. Exp. Gerontol. 35:481-87
47. Haass C, Hung AY, Selkoe DJ, Teplow DB. 1994. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J. Biol. Chem. 269:17741-48
48. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322-25
49. Harper JD, Wong SS, Lieber CM, Lansbury PT. 1997. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:119-25
50. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, et al. 1999. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:8876-84
51. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, et al. 2000. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20:7951-63
52. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:97-100
53. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, et al. 2000. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97:2892-97
54. Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, et al. 1999. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103:R15-21
55. Huppert S, Le A, Schroeter E, Mumm J, Saxena M, et al. 2000. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405:966-70
56. Hyman BT, Strickland D, Rebeck GW. 2000. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer's disease. Arch. Neurol. 57:646-50
57. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43). Neuron 13:45-53
58. Jarrett JT, Berger EP, Lansbury PT Jr. 1993. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-97
59. Kim TW, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE. 1997. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272:11006-10
60. Kimberly W, Zheng J, Guenette S, Selkoe D. 2001. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner. J. Biol. Chem. 276:40288-92
61. Kimberly WT, Xia W, Rahmati R, Wolfe MS, Selkoe DJ. 2000. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation. J. Biol. Chem. 275:3173-78
62. Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV. 2001. Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling. J. Biol. Chem. 276:7366-75
63. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA 98:5815-20
64. Kopan R, Goate A. 2002. Aph-2/Nicastrin: An essential component of gammasecretase and regulator of Notch signaling and presenilin localization. Neuron 33:321-24
65. Kopan R, Schroeter EH, Weintraub H, Nye JS. 1996. Signal transduction by activated mNotch: Importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl. Acad. Sci. USA 93:1683-88
66. Kovacs DM, Fausett HJ, Page KJ, Kim T-W, Mori RD, et al. 1996. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:224-29
67. Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, et al. 1997. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17:1971-80
68. Lambert JC, Goumidi L, Vrieze FW, Frigard B, Harris JM, et al. 2000. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum. Mol. Genet. 9:2275-80
69. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95:6448-53
70. Le TV, Crook R, Hardy J, Dickson DW. 2001. Cotton wool plaques in non-familial late-onset Alzheimer's disease. J. Neuropathol. Exp. Neurol. 60:1051-61
71. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. 1996. Sequence of deposition of heterogeneous amyloid beta-peptides and Apo E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:16-32
72. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, et al. 1996. The E280A presenilin-1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2:1146-50
73. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, et al. 1996. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93:14940-44
74. Levitan D, Greenwald I. 1995. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377:351-54
75. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, et al. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-26
76. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-77
77. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, et al. 1995. A familial Alzheimer's disease locus on chromosome 1. Science 269:970-73
78. Lewis J, Dickson DW, Lin W, Chisholm L, Corral A, et al. 2001. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-91
79. Li X, Greenwald I. 1998. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc. Natl. Acad. Sci. USA 95:7109-14
80. Li Y-M, Xu M, Lai M-T, Huang Q, Castro JL, et al. 2000. Photoactivated γsecretase inhibitors directed to the active site covalently label presenilin 1. Nature 405:689-94
81. Lorenzo A, Yankner B. 1994. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91:12243-47
82. Luo L, Tully T, White K. 1992. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9:595-605
83. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. 1994. The amyloid-associated proteins α 1-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments. Nature 372:92-94
84. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:379-89
85. Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, et al. 2000. Substitutions at codon 22 of Alzheimer's Abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275:27110-16
86. Murphy GM Jr, Claassen JD, DeVoss JJ, Pascoe N, Taylor J, et al. 2001. Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha-889 * 1 allele. Neurology 56:1595-97
87. Myers AJ, Goate AM. 2001. The genetics of late-onset Alzheimer's disease. Curr. Opin. Neurol. 14:433-40
88. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. 1991. Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541:163-66
89. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, et al. 1998. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21:1213-21
90. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. 1994. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264:850-52
91. Natté R, Maat-Schieman M, Haan J, Bomebroek M, Roos R, Van Duinen S. 2001. Dementia in hereditary cerebral hemorrhage with amyloidosisDutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol. 50:765-72
92. Ni CY, Murphy MP, Golde TE, Carpenter G. 2001. Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-81
93. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, et al. 2001. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4:887-93
94. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, et al. 1995. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. Br. Med. J. 310:970-73
95. Perez RG, Zheng H, Van der Ploeg LH, Koo EH. 1997. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17:9407-14
96. 299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3:325-37
97. Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, et al. 1998. Molecular mapping of Alzheimer-type dementia in Down syndrome. Ann. Neurol. 43:380-83
98. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, et al. 1998. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. Neuron 20:611-17
99. Ray WJ, Yao M, Mumm J, Schroeter EH, Saftig P, et al. 1999. Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of notch. J. Biol. Chem. 274:36801-7
100. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. 1993. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-80
101. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-78
102. Rogers J, Webster S, Lue L-F, Brachova L, Civin WH, et al. 1996. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17:681-86
103. Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, et al. 2001. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2:835-41
104. Saunders AM. 2000. Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses. J. Neuropathol. Exp. Neurol. 59:751-58
105. Schellenberg GD, Bird TD, Wijsman EM, Moore DK, Boehnke M, et al. 1988. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science 241:1507-10
106. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, et al. 1992. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258:668-71
107. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, et al. 1999. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-77
108. Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:864-70
109. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, et al. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:9649-53
110. Schroeter EH, Kisslinger JA, Kopan R. 1998. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-86
111. Schwarzman AL, Singh N, Tsiper M, Gregori L, Dranovsky A, et al. 1999. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc. Natl. Acad. Sci. USA 96:7932-37
112. Selkoe D. 2001. Clearing the brain's amyloid cobwebs. Neuron 32:177-80
113. Selkoe DJ. 2001. Alzheimer's disease: Genes, proteins and therapies. Physiol. Rev. 81:742-61
114. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in presnilin-1 deficient mice. Cell 89:629-39
115. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-60
116. Sisodia SS. 1992. β-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89:6075-79
117. Song W, Nadeau P, Yuan M, Yang X, Shen J, Yankner BA. 1999. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl. Acad. Sci. USA 96:6959-63
118. St George-Hyslop PH. 2000. Molecular genetics of Alzheimer's disease. Biol. Psychol. 47:183-99
119. St George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C, et al. 1990. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature 347:194-97
120. Steiner H, Capell A, Pesold B, Citron M, Kloetzek PM, et al. 1998. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273:32322-31
121. Steiner H, Kostka M, Romig H, Basset G, Pesold B, et al. 2000. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nat. Cell Biol. 2:848-51
122. Steiner H, Romig H, Grim MG, Philipp U, Pesold B, et al. 1999. The biological and pathological function of the presenilin-1 deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274:7615-18
123. Steiner H, Romig H, Pesold B, Philipp U, Baader M, et al. 1999. Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry 38:14600-5
124. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, et al. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in lateonset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:1977-81
125. Struhl G, Adachi A. 2000. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol. Cell 6:625-36
126. Struhl G, Greenwald I. 1999. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398:522-25
127. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, et al. 1994. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264:1336-40
128. Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, et al. 1996. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2:93-95
129. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, et al. 1996. Endoprotreolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17:181-90
130. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, et al. 1997. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:28415-22
131. Thinakaran G, Regard JB, Bouton CML, Harris CL, Price DL, et al. 1998. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4:438-53
132. Tokuda T, Fukushima T, Ikeda S, Sekijima Y, Shoji S, et al. 1997. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Ann. Neurol. 41:271-73
133. Tomita T, Tokuhiro S, Hashimoto T, Aiba K, Saido TC, et al. 1998. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42. J. Biol. Chem. 273:21153-60
134. Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, et al. 2000. The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 20:3937-46
135. van Duijn CM, Clayton D, Chandra V, Fratiglioni L, Graves AB, et al. 1991. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:S13-20
136. Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, Rebeck GW. 2001. Pathogenic effects of D23N Iowa mutant amyloid beta-protein. J. Biol. Chem. 276:32860-66
137. Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. 1999. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neurosci. Lett. 265:218-22
138. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. 2002. Naturally secreted oligomers of amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-39
139. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. 1997. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272:22364-72
140. Wang Z, Natte R, Berliner JA, van Duinen SG, Vinters HV, Rosenblum WI. 2000. Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 31:534-38
141. Weidemann A, Paliga K, Durrwang U, Czech C, Evin G, et al. 1997. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein. Nat. Med. 3:328-32
142. Wolfe MS, Citron M, Diehl TS, Xia W, Donkor IO, Selkoe DJ. 1998. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity. J. Med. Chem. 41:6-9
143. Wolfe MS, Xia W, Moore CL, Leatherwood DD, Ostaszewski BL, et al. 1999. Peptidomimetic probes and molecular modeling suggest Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38:4720-27
144. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and y-secretase activity. Nature 398:513-17
145. Wong P, Zhen H, Chen H, Becher MW, Sirinathsinghji DJ, et al. 1997. Presenilin 1 is required for Notch1 and D111 expression in the paraxial mesoderm. Nature 397:288
146. Xia W, Ray WJ, Ostaszewski BL, Rahmati T, Kimberly WT, et al. 2000. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation. Proc. Natl. Acad. Sci. USA 97:9299-304
147. Xia W, Zhang J, Kholodenko D, Citron, M, Podlisny MB, et al. 1997. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:7977-82
148. Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, et al. 1998. Presenilin 1 regulates the processing APP C-terminal fragments and the generation of amyloid β-protein in ER and golgi. Biochemistry 37:16465-71
149. Xia W, Zhang J, Perez R, Koo EH, Selkoe DJ. 1997. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94:8208-13
150. Ye Y, Lukinova N, Fortini ME. 1999. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 398:525-29
151. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, et al. 1998. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J. Biol. Chem. 273:16470-75
152. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, et al. 2000. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407:48-54
153. Zhang J, Kang DE, Xia W, Okochi M, Mori H, et al. 1998. Subcellular distribution and turnover of presenilins in transfected cells. J. Biol. Chem. 273:12436-42
154. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, et al. 1995. Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81:525-31
155. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, et al. 1997. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. NeuroReport 8:2085-90